SelectQuote (NYSE:SLQT - Get Free Report) released its earnings results on Wednesday. The company reported ($0.21) EPS for the quarter, beating the consensus estimate of ($0.33) by $0.12, FiscalAI reports. The business had revenue of $280.01 million during the quarter, compared to analyst estimates of $277.91 million. SelectQuote had a net margin of 3.84% and a return on equity of 19.70%.
Here are the key takeaways from SelectQuote's conference call:
- Adjusted EBITDA loss improved by more than $15 million year over year to $17 million, despite revenue falling 15% to $280 million. Management reiterated its target of at least $60 million in fiscal 2027 operating cash flow.
- SelectQuote is operating with a smaller Senior agent force and is prioritizing profitability over sales volume amid continued Medicare Advantage plan changes. The company has not changed its cautious outlook for policy volumes, though it said agent productivity and technology may help offset the headwind.
- Early AEP engagement is encouraging, and agents have contacted more than half of beneficiaries facing plan terminations; management aims to exceed last year’s 30% recapture rate. Executives emphasized that results are still early and the season remains dynamic.
- Healthcare Services adjusted EBITDA rose 56% to $11 million and EBITDA per SelectRx member increased more than 60%, even as segment revenue fell 16%, primarily due to the Inflation Reduction Act. Management expects the pharmacy management system and facility efficiencies to support further margin improvement, including a goal to double Healthcare Services margins in fiscal 2027.
- The company said it has removed more than $30 million in permanent annualized costs and is using AI to improve agent productivity and streamline enrollment. Management cited faster automated enrollments and expects these technology investments to support profitability and scalability.
SelectQuote Stock Performance
Shares of SLQT traded up $0.09 during trading hours on Wednesday, reaching $0.50. 5,090,436 shares of the company traded hands, compared to its average volume of 1,545,860. SelectQuote has a 1-year low of $0.30 and a 1-year high of $2.17. The company has a debt-to-equity ratio of 0.99, a quick ratio of 6.57 and a current ratio of 6.57. The stock has a market cap of $88.91 million, a P/E ratio of -6.27 and a beta of 2.01. The stock's fifty day moving average is $0.43 and its 200 day moving average is $0.78.
Analysts Set New Price Targets
A number of research firms recently weighed in on SLQT. Zacks Research upgraded SelectQuote from a "strong sell" rating to a "hold" rating in a research report on Monday, October 26th. Wall Street Zen downgraded shares of SelectQuote from a "hold" rating to a "sell" rating in a research note on Saturday, August 29th. Finally, Weiss Ratings downgraded SelectQuote from a "sell (d+)" rating to a "sell (d)" rating in a report on Monday, August 17th. One equities research analyst has rated the stock with a Strong Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Hold" and a consensus target price of $3.00.
Read Our Latest Stock Analysis on SelectQuote
SelectQuote Company Profile
(
Get Free Report)
SelectQuote, Inc NYSE: SLQT operates a technology-enabled insurance distribution platform that helps consumers compare and purchase insurance products from third-party carriers. The company combines digital tools, proprietary data and licensed agents to connect customers with coverage suited to their needs.
SelectQuote's primary business is its Senior segment, which provides access to Medicare Advantage, Medicare Supplement and prescription drug plans. The company has also historically offered life insurance, as well as auto and home insurance, through its Life and Auto & Home businesses.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider SelectQuote, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and SelectQuote wasn't on the list.
While SelectQuote currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.